Mittendorf R[au] - Search Results

Year	Number of Results
1980	1
1990	2
1991	7
1992	4
1993	9
1994	7
1995	13
1996	8
1997	3
1998	10
1999	6
2000	5
2001	8
2002	5
2003	2
2004	6
2005	3
2006	2
2007	1
2008	1
2009	2
2011	2
2012	1
2014	1
2022	0

1

DES exposure: an update.

Mittendorf R, Herbst AL. Mittendorf R, et al. Contemp Pediatr. 1994 Nov;11(11):59-62, 64, 66 passim. Contemp Pediatr. 1994. PMID: 10150281 Review.

2

Risk-benefit effects of tocolytic therapy.

Pryde PG, Janeczek S, Mittendorf R. Pryde PG, et al. Among authors: mittendorf r. Expert Opin Drug Saf. 2004 Nov;3(6):639-54. doi: 10.1517/14740338.3.6.639. Expert Opin Drug Saf. 2004. PMID: 15500422 Review.

3

The magpie trial.

Mittendorf R, Pryde PG, Herschel M, Lee KS. Mittendorf R, et al. Lancet. 2002 Oct 26;360(9342):1330-1; author reply 1331-2. doi: 10.1016/S0140-6736(02)11323-7. Lancet. 2002. PMID: 12414229 No abstract available.

4

A review of the role for magnesium sulphate in preterm labour.

Mittendorf R, Pryde PG. Mittendorf R, et al. BJOG. 2005 Mar;112 Suppl 1:84-8. doi: 10.1111/j.1471-0528.2005.00592.x. BJOG. 2005. PMID: 15715602 Review.

5

Adverse and beneficial effects of tocolytic therapy.

Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R. Pryde PG, et al. Among authors: mittendorf r. Semin Perinatol. 2001 Oct;25(5):316-40. doi: 10.1053/sper.2001.27547. Semin Perinatol. 2001. PMID: 11707019 Review.

6

Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose.

Pryde PG, Mittendorf R. Pryde PG, et al. Among authors: mittendorf r. Obstet Gynecol. 2009 Sep;114(3):669-673. doi: 10.1097/AOG.0b013e3181b43b0e. Obstet Gynecol. 2009. PMID: 19701048 Review.

7

Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.

Mittendorf R, Dammann O, Lee KS. Mittendorf R, et al. J Perinatol. 2006 Jan 1;26(1):57-63. doi: 10.1038/sj.jp.7211419. J Perinatol. 2006. PMID: 16319938 Review.

8

Relationship between hypermagnesaemia in preterm labour and adverse health outcomes in babies.

Mittendorf R, Pryde PG, Elin RJ, Gianopoulos JG, Lee KS. Mittendorf R, et al. Magnes Res. 2002 Dec;15(3-4):253-61. Magnes Res. 2002. PMID: 12635881 Review.

9

Using prophylactic, but not tocolytic, magnesium sulfate to reduce cerebral palsy related to prematurity: what dose, and what about infant mortality?

Pryde PG, Mittendorf R. Pryde PG, et al. Among authors: mittendorf r. J Perinat Med. 2011 Jul;39(4):375-8. doi: 10.1515/jpm.2011.036. Epub 2011 Apr 14. J Perinat Med. 2011. PMID: 21488809 Review.

10

Second overview of relationships between antenatal pharmacologic magnesium sulfate and neurologic outcomes in children.

Mittendorf R, Pryde PG, Roizen N. Mittendorf R, et al. J Perinat Med. 2004;32(3):201-10. doi: 10.1515/JPM.2004.038. J Perinat Med. 2004. PMID: 15188791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results